tm logo
DISCOVERY LABS
Dead/Abandoned
ABANDONED - NO STATEMENT OF USE FILED

no statement of use filed

on 06 Nov 2023

Last Applicant/ Owned by

201 King of Prussia Road, Suite 501

Radnor

PA

19087

Serial Number

88729359 filed on 16th Dec 2019

Registration Number

N/A

Correspondent Address

Joshua M. Gerben, Esq.

Joshua M. Gerben, Esq. GERBEN LAW FIRM, PLLC

SUITE 500

WASHINGTON, DC 20036

UNITED STATES

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

DISCOVERY LABS

Research and development services in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; Consulting services in the fields of research and development for gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; Research and development of new products for others; Process development services in the nature Read More

Classification Information


Class [045]
Personal & Legal & Social Services


Regulatory compliance consulting in the fields of pharmaceuticals, medicines, biopharmaceuticals, and gene therapy


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [042]
Computer & Software Services & Scientific Services


Research and development services in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; Consulting services in the fields of research and development for gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; Research and development of new products for others; Process development services in the nature of research and development of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; Scientific research and technical research services, namely, production of cell lines for others using lentivirus technology; Scientific research and technical research services relating to producing, assaying and purifying recombinant or manipulated lentivirus; Scientific and technical consulting services relating to producing, assaying, and purifying adenovirus, adeno-associated virus (AAV), bacteriophage, lentivirus, retroviruses and other viruses found in humans and animals; advisory services relating to research and development of gene therapy products and biopharmaceuticals; manufacturing support services for others, namely, cGMP (Current Good Manufacturing Practice) quality control testing in support of biopharmaceutical development and manufacturing; Quality control for others; Quality management services, namely, quality evaluation and analysis, quality assurance, and quality control, in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; Material testing; Product quality testing; Scientific laboratory services; Scientific research


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [040]
Treatment & Processing of Materials Services


Manufacturing services for others in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; Manufacturing services for others in the fields of mammalian cell banks, plasmids, adenovirus, adeno-associated virus (AAV), bacteriophage, lentivirus, retroviruses and other viruses found in humans and animals; Manufacturing process consulting


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 88729359

Mark Type

No Service Mark

Attorney Docket Number

No 07768-0008

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
06th Nov 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
06th Nov 2023ABANDONMENT - NO USE STATEMENT FILED
05th Apr 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03rd Apr 2023SOU EXTENSION 4 GRANTED
03rd Apr 2023SOU EXTENSION 4 FILED
03rd Apr 2023SOU TEAS EXTENSION RECEIVED
20th Sep 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
16th Sep 2022SOU EXTENSION 3 GRANTED
16th Sep 2022SOU EXTENSION 3 FILED
16th Sep 2022SOU TEAS EXTENSION RECEIVED